ConductScience.org, home

Paper42889486PubMed

Spatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validation.

Liu G and 8 others. Front Immunol, 2026.

Cite this record

ConductScience Library. Spatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validation. Papers, record 42889486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validation.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-19

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu GGaojie
2Yang JJunwei
3Li HHan
4Deng LLishuo
5Jiang LLiuxin
6Tan YYuetong
7Zhu JJianxiong
8Li JJifan
9Wang YYao

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
ImmunotherapyMajor topic
Lymphoma, Large B-Cell, DiffuseMajor topic
Drug Resistance, NeoplasmMajor topic
Humans
Animals
Multiomics
Single-Cell Analysis

Source PubMed

Download CSV of topics

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018https://conductscience.org/library/papers/29713087PubMed
232301585Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy.Cancer Commun (Lond)2020https://conductscience.org/library/papers/32301585PubMed
337308475Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma.Cell Discov2023https://conductscience.org/library/papers/37308475PubMed
440453362The integration of single-cell RNA sequencing and spatial transcriptomics reveals the tumor microenvironment and spatial organization of testicular diffuse large B-cell lymphomas.Genes Dis2025https://conductscience.org/library/papers/40453362PubMed
536507690Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.N Engl J Med2022https://conductscience.org/library/papers/36507690PubMed
634656878Lactate in the tumour microenvironment: From immune modulation to therapy.EBioMedicine2021https://conductscience.org/library/papers/34656878PubMed
735717989
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet2022https://conductscience.org/library/papers/35717989PubMed
833657296Diffuse Large B-Cell Lymphoma.N Engl J Med2021https://conductscience.org/library/papers/33657296PubMed
929075266Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors.Front Immunol2017https://conductscience.org/library/papers/29075266PubMed
1030918399CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape.Nature2019https://conductscience.org/library/papers/30918399PubMed
1138459052Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma.Nat Commun2024https://conductscience.org/library/papers/38459052PubMed
1233969247The landscape of cell-cell communication through single-cell transcriptomics.Curr Opin Syst Biol2021https://conductscience.org/library/papers/33969247PubMed
1339998673Spatial transcriptomics reveals prognostically LYZ+ fibroblasts and colocalization with FN1+ macrophages in diffuse large B-cell lymphoma.Cancer Immunol Immunother2025https://conductscience.org/library/papers/39998673PubMed
1441061154Myeloid landscape profiling identifies DLBCL-specific suppressive macrophages colocalized with blood endothelial cells.Blood Adv2026https://conductscience.org/library/papers/41061154PubMed
1536038629Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.Nat Med2022https://conductscience.org/library/papers/36038629PubMed
1610676951Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature2000https://conductscience.org/library/papers/10676951PubMed
1735675517Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma.Blood Adv2022https://conductscience.org/library/papers/35675517PubMed
1835443163A single-cell atlas of diffuse large B cell lymphoma.Cell Rep2022https://conductscience.org/library/papers/35443163PubMed
1928341790Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody-Drug Conjugates.Mol Cancer Ther2017https://conductscience.org/library/papers/28341790PubMed
2042088615Indole-3-Carbaldehyde from Limosilactobacillus reuteri Boosts Chemotherapy Response in Diffuse Large B Cell Lymphoma by Blocking the Mechanistic Target of Rapamycin Pathway.Research (Wash D C)2026https://conductscience.org/library/papers/42088615PubMed

See all 59 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42889486

GET https://conductscience.org/api/papers/v1/42889486/references?page=2